Menu
Menu
Introducing
Our Portfolio
Pedro Fernandes, Founder and CEO Bullet Solutions
António Silva, Founder and CEO Nonius
Mário Gadanho, Founder Biopremier
Rui A. Sousa, Founder and CEO Stemmatters
“It is always easy to talk about a good partner. From Beta Capital you can expect honesty and firmness in opinions, but always with the necessary flexibility to know how to listen and work as a team, in order to arrive at better decisions. I don’t forget that they were always by our side, especially in some difficult moments.“
Pedro Fernandes, Founder and CEO Bullet Solutions
António Silva, Founder and CEO Nonius
PORTFOLIO NEWS
Entry Year: 2006
Exit Year: 2018
Entry Year: 2006
Exit Year: 2013
Global services company performing testing and technical analysis in the environmental area.
Entry Year: 2006
Exit Year: 2012
Entry Year: 2006
Exit Year: 2019
Venture capital firm seeking to invest in seed and early-stage companies operating in the in the life sciences, oncology, healthcare and pharmaceuticals sectors.
Entry Year: 2006
Exit Year: 2016
Diagnostic company based on real time PCR kits created to serve the agri-food, clinical and veterinary sectors.
Entry Year: 2006
First and only diagnostic company diagnostics system capable of performing the major PoC blood test modalities (hematology, immunoassays and clinical chemistry) on the same instrument. Developer of the spinit technology, a fully automated diagnostics solution with just one drop of blood.
Entry Year: 2014
SaaS company developer of scheduling and timetabling software designed to automatically solve complex processes and decisions.
Entry Year: 2006
Exit Year: 2019
Venture capital firm supporting university spin-offs, researchers or business projects, in the areas of physical sciences and engineering.
Entry Year: 2012
Exit Year: 2016
Entry Year: 2007
Exit Year: 2020
Biotechnology company dedicated to the development of a new targeted treatment for obesity.
Entry Year: 2022
Entry Year: 2023
Entry Year: 2015
Exit Year: 2020
Digital health and genetic testing company using machine learning methods and data analytics to provide actionable and cost-effective genetic tests with highly scalable applications in well-being, cardiovascular genetics and pharmacogenetics
Entry Year: 2008
Software company developer of a decision-making tool designed to assist Ph.D. students coherently align the theory, method, data, rhetoric and authorship of a research proposal.
Entry Year: 2014
Exit Year: 2020
Biotechnology company dedicated to the development the next generation of fully portable, easy to use in-vitro molecular diagnostic devices, in particular the detection of bovine mastitis causing pathogens in milk.
Entry Year: 2011
Exit Year: 2020
Biotechnology company dedicated to the development of bio-nanotechnology designed to offer development services of materials and surfaces with antimicrobial properties.
Entry Year: 2006
Exit Year: 2015
Entry Year: 2023
Nutrium is a Portuguese start-up that developed online nutrition software created with the aim of simplifying the tasks of nutrition professionals and improving monitoring between appointments, being widely used by independent nutritionists, nutrition clinics, hospitals and gyms.
Entry Year: 2009
Exit Year: 2011
Industrial company dedicated to the development, production and commercialization of heat pumps and other solutions for increasing energy efficiency
Entry Year: 2011
Biotechnology company provinding CDMO services in cell therapies, tissue products and blood-derived biologicals, complemented with a hydrogel formulation platform. Stemmatters’ STM-148B has been specifically designed as a proprietary, fully chemically defined, biodegradable matrix for cartilage repair applications.
Entry Year: 2007
Exit Year: 2016
Pharmaceutical company dedicated to targeted drug discovery platform, with drug candidates in two orphan diseases characterised by tight junction defect.
Entry Year: 2023
Vawlt is a visionary start-up with a unique, long-term supercloud (cloud-of-clouds) distributed storage solution that offers unmatched levels of privacy, security, and availability. Easy to use, secure and resilient by default, Vawlt’s solution enables companies to choose the best-of-breed from multiple storage environments: from public to private clouds to on-premises, all while simplifying processes, optimizing costs, and improving control over data. Vawlt puts companies in the driving seat over sovereignty, scalable storage volumes, and cost efficiency
Entry Year: 2021
WeNou provides innovative services based on DNA analysis, especially focused on Next Generation Sequencing (NGS) technology, starting with applications for the food industry, where the supply chain stakeholders show increasing concerns about food authenticity, safety, and quality, while consumers are demanding more accurate information about the products.
